Genetic Technologies Becomes Distributor for Response Genetics in Asia

Genetic Technologies has executed an Exclusive Test Distribution and Services Agreement with Response Genetics, under which the former will become the exclusive distributor in Australia, Indonesia, Malaysia, the Philippines, Singapore and Thailand.

This is for the latter’s colon, lung and gastric genetic test panels, proprietary Polymerase Chain Reaction (PCR)-based molecular diagnostic tests for cancer.

Dr Paul MacLeman, CEO of Genetic Technologies said, “This is an important further step in Genetic Technologies’ move into advanced cancer management. As previously announced, we are seeking to leverage in-house developed tests through partnerships with third party developers of novel tests.”